Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...
Parkinson's disease: early signs and symptoms to look out for after John Stapleton reveals diagnosis
BBC presenter John Stapleton has revealed he has been diagnosed with Parkinson’s disease. The 78-year-old who is best known ...
Tuesday, Sept. 24, former Green Bay Packer and NFL Hall of Fame quarterback Brett Favre testified before Congress. Favre was ...
Slow movement, tremor, and stiff muscles are all typical symptoms of Parkinson’s disease. They are due to loss of the ...
The chemical messenger dopamine is an essential catalyst that fuels activities and behaviors ranging from movement to ...
"We, 100% can tell everyone who comes in the room who is diagnosed with PD, if you exercise, your disease will go slower than ...
A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A ...
MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ...
PHILADELPHIA — Continuous intracerebroventricular administration of an anaerobic dopamine formulation (A-dopamine) appears safe in patients with Parkinson's disease (PD) and may avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback